Company Badge
USPTO Data Jan 1 1976 - Oct 20 2026
545 Patents
#1 in Rixensart
#6 in Belgium
#1,787 in the World
Glaxosmithkline Biologicals Sa
Forward Citations = 2,346
572 inventors:
Glaxosmithkline Biologicals Sa
Calculating rank
% Expired Patents = 25.1
CIPO Patents = 33
EPO Patents = 356
Trademarks = 111
Forward Citations = 2,346
Loading Chart...
Loading Chart...
572 inventors (with patents filed for the assignee):
Andrew John Geall (53 out of 101 patents)
Jan Poolman (45 out of 47 patents)
Mariagrazia Pizza (35 out of 82 patents)
4. Ralph Leon Biemans (34 out of 34 patents)
5. Michael T Kowarik (30 out of 37 patents)
6. Maria Scarselli (27 out of 59 patents)
7. Francesco Berti (24 out of 31 patents)
8. Paolo Costantino (24 out of 35 patents)
9. Guido Grandi (24 out of 111 patents)
10. Gillis Otten (22 out of 24 patents)
11. Manmohan Singh (22 out of 54 patents)
12. Derek T O'Hagan (22 out of 73 patents)
13. Katrin Ramsauer (20 out of 22 patents)
14. Christian Walter Mandl (20 out of 20 patents)
15. Normand Blais (20 out of 21 patents)
Core Competencies:
Vaccine
RNA Vaccine
Adjuvant
Polysaccharide
Nucleic Acids
Immunogenic Composition
Saponin Purification
Lipid Formulations
Bioconjugates
Meningococcal
Immunization Regimen
Epstein-Barr Virus
545 patents:
Company Overview
GlaxoSmithKline Biologicals SA, headquartered in Rixensart, Belgium, is a leader in vaccine development, focusing on innovative solutions to prevent infectious diseases. The company specializes in a range of technologies including RNA vaccines, adjuvants, and immunogenic compositions, leveraging advanced methodologies such as polysaccharide and lipid formulations. GSK Biologicals is committed to enhancing global health through its extensive research and development efforts in the field of immunization.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Glaxosmithkline Biologicals Sa. Retrieved from https://idiyas.com/company/glaxosmithkline-biologicals-sa
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
33 patents (CIPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
356 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]